Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 87 Show results per page	View Search Criteria \| Help With Results

Last Modified: 6/6/2008 First Published: 6/23/2004


1.		Phase IV Randomized Study of Rasburicase Alone Versus Rasburicase and Allopurinol Versus Allopurinol Alone in Patients With Leukemia, Lymphoma, or Solid Tumor Malignancy at Risk for Hyperuricemia and Tumor Lysis Syndrome

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Closed				18 and over				Pharmaceutical / Industry				PROLOGUE-EFC4978 UCLA-0403071-01, NCT00230178


2.		Phase II/III Consolidation Chemotherapy with VP-16/AMSA/AZC Following Induction with DNM/ARA-C/TG for Adult Primary or Secondary Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 and over								NCI-D82-051-605

Last Modified: 8/10/2007


3.		Phase II/III Pilot Combination Chemotherapy and Radiotherapy for Previously Untreated Childhood ALL with Poor Prognosis

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				under 21				NCI				CCG-192P

Last Modified: 11/9/2005


4.		Phase II/III Randomized Study of Standard-Dose vs High-Dose MTX Followed by Induction and Continuation for Patients with ALL or AUL

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								DFCI-81001 NCI-D82-018-0400, D82-018-0400

Last Modified: 5/23/2007


5.		Phase III Pilot Intensification with High-Dose ARA-C and Consolidation with MACHO (CTX/ADR/VCR/PRED/MTX/L-ASP) for Adult ALL

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				15 to 65				NCI				EST-2483


6.		Phase III Chemotherapy with 5-FU and Allopurinol vs 5-FU Alone for Previously Untreated Metastatic Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								SEG-GI-82389

Last Modified: 4/1/1997


7.		Phase III Pre- and Postoperative Combination Chemotherapy Including High-Dose MTX in Children with Previously Untreated Nonmetastatic Osteogenic Sarcoma of an Extremity (Summary Last Modified 04/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				2 to 21				NCI				CCG-782


8.		Phase III Intensive Reinduction Followed by Intensive Maintenance vs Conventional Maintenance Chemotherapy in Relapsed Childhood ALL and AUL

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				21 and under				NCI				NCI-82-C-199 NCI-POB-7709, NCI-T83-0966N, T83-0966

Last Modified: 6/18/2007


9.		Phase III Total Sanctuary vs Conventional CNS Treatment for Newly Diagnosed Acute Lymphoblastic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				under 21				NCI				CCG-191 NCI-82-C-200, NCI-POB-7702

Last Modified: 6/28/2004


10.		Phase III Randomized Comparison of Chemotherapy with CHOP (CTX/ADR/VCR/PRED) Alone vs CHOP plus Radiotherapy Consolidation for Unfavorable Early Stage non-Hodgkin's Lymphoma (Summary Last Modified 09/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				16 and over				NCI				EST-1484

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute